• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多粘菌素甲磺酸盐处理的结核分枝杆菌的代谢组学

Metabolomics of colistin methanesulfonate treated Mycobacterium tuberculosis.

作者信息

Koen Nadia, van Breda Shane Vontelin, Loots Du Toit

机构信息

Human Metabolomics, North-West University, Private Bag x6001, Box 269, Potchefstroom, 2531, South Africa.

Department of Internal Medicine, Division of Infectious Diseases, University of Pretoria, Pretoria, 0002, South Africa.

出版信息

Tuberculosis (Edinb). 2018 Jul;111:154-160. doi: 10.1016/j.tube.2018.06.008. Epub 2018 Jun 13.

DOI:10.1016/j.tube.2018.06.008
PMID:30029902
Abstract

Over the past 5 years, there has been a renewed interest in finding new compounds with anti-TB action. Colistin methanesulfonate or polymyxin E, is a possible anti-TB drug candidate, which may in future be used either alone or in combination to the current 6 month "directly observed treatment short-course" (DOTS) regimen. However its mechanism of action has to date not yet been fully explored, and only described from a histological and genomics perspective. Considering this, we used a GCxGC-TOFMS metabolomics approach and identified those metabolite markers characterising Mycobacterium tuberculosis (Mtb) cultured in the presence of colistin methanesulfonate, in order to better understand or confirm its mechanism of action. The metabolite markers identified indicated a flux in the metabolism of the colistin methanesulfonate treated Mtb towards fatty acid synthesis and cell wall repair, confirming previous reports that colistin acts by disrupting the cell wall of mycobacteria. Accompanying this, is a subsequently elevated glucose uptake, since the latter now serves as the primary energy substrate for the upregulated glyoxylate cycle, and additionally as a precursor for further fatty acid synthesis via the glycerolipid metabolic pathway. Furthermore, the elevated concentrations of those metabolites associated with pentose phosphate, valine, threonine, and pentanediol metabolism, also confirms a shift towards glucose utilization for energy production, in the colistin methanesulfonate treated Mtb.

摘要

在过去5年里,人们对寻找具有抗结核作用的新化合物重新产生了兴趣。黏菌素甲磺酸盐或多黏菌素E是一种可能的抗结核药物候选物,未来可能单独使用或与目前的6个月“直接观察短程治疗”(DOTS)方案联合使用。然而,其作用机制迄今为止尚未得到充分探索,仅从组织学和基因组学角度进行了描述。考虑到这一点,我们采用了全二维气相色谱-飞行时间质谱代谢组学方法,鉴定了在黏菌素甲磺酸盐存在下培养的结核分枝杆菌(Mtb)的代谢物标志物,以便更好地理解或确认其作用机制。鉴定出的代谢物标志物表明,经黏菌素甲磺酸盐处理的Mtb的代谢朝着脂肪酸合成和细胞壁修复方向流动,这证实了先前关于黏菌素通过破坏分枝杆菌细胞壁起作用的报道。与此同时,葡萄糖摄取随后增加,因为后者现在作为上调的乙醛酸循环的主要能量底物,并且还作为通过甘油脂质代谢途径进一步合成脂肪酸的前体。此外,与磷酸戊糖、缬氨酸、苏氨酸和戊二醇代谢相关的那些代谢物浓度升高,也证实了在经黏菌素甲磺酸盐处理的Mtb中,朝着利用葡萄糖产生能量的方向转变。

相似文献

1
Metabolomics of colistin methanesulfonate treated Mycobacterium tuberculosis.多粘菌素甲磺酸盐处理的结核分枝杆菌的代谢组学
Tuberculosis (Edinb). 2018 Jul;111:154-160. doi: 10.1016/j.tube.2018.06.008. Epub 2018 Jun 13.
2
Elucidating the antimicrobial mechanisms of colistin sulfate on Mycobacterium tuberculosis using metabolomics.运用代谢组学阐明硫酸黏菌素对结核分枝杆菌的抗菌机制。
Tuberculosis (Edinb). 2018 Jul;111:14-19. doi: 10.1016/j.tube.2018.05.001. Epub 2018 May 8.
3
The antimicrobial effect of colistin methanesulfonate on Mycobacterium tuberculosis in vitro.多粘菌素甲磺酸钠对结核分枝杆菌的体外抗菌作用。
Tuberculosis (Edinb). 2015 Jul;95(4):440-6. doi: 10.1016/j.tube.2015.05.005. Epub 2015 May 21.
4
Colistin as a potentiator of anti-TB drug activity against Mycobacterium tuberculosis.黏菌素作为抗结核药物对结核分枝杆菌活性的增强剂。
J Antimicrob Chemother. 2015 Oct;70(10):2828-37. doi: 10.1093/jac/dkv194. Epub 2015 Jul 16.
5
New sputum metabolite markers implicating adaptations of the host to Mycobacterium tuberculosis, and vice versa.新的痰液代谢物标志物提示宿主与结核分枝杆菌相互适应,反之亦然。
Tuberculosis (Edinb). 2013 May;93(3):330-7. doi: 10.1016/j.tube.2013.02.008. Epub 2013 Mar 7.
6
Characterization of urinary metabolites as biomarkers of colistin-induced nephrotoxicity in rats by a liquid chromatography/mass spectrometry-based metabolomics approach.基于液相色谱/质谱联用代谢组学方法对大鼠中作为黏菌素诱导肾毒性生物标志物的尿液代谢物进行表征。
Toxicol Lett. 2016 Apr 25;248:52-60. doi: 10.1016/j.toxlet.2016.02.018. Epub 2016 Mar 3.
7
New insights into the survival mechanisms of rifampicin-resistant Mycobacterium tuberculosis.耐利福平结核分枝杆菌生存机制的新见解。
J Antimicrob Chemother. 2016 Mar;71(3):655-60. doi: 10.1093/jac/dkv406. Epub 2015 Dec 17.
8
Elucidating the Antimycobacterial Mechanism of Action of Ciprofloxacin Using Metabolomics.利用代谢组学阐明环丙沙星的抗分枝杆菌作用机制
Microorganisms. 2021 May 28;9(6):1158. doi: 10.3390/microorganisms9061158.
9
Activity of moxifloxacin and linezolid against Mycobacterium tuberculosis in combination with potentiator drugs verapamil, timcodar, colistin and SQ109.莫西沙星和利奈唑胺联合维拉帕米、替莫唑胺、黏菌素和 SQ109 对结核分枝杆菌的活性。
Int J Antimicrob Agents. 2017 Mar;49(3):302-307. doi: 10.1016/j.ijantimicag.2016.11.027. Epub 2017 Feb 2.
10
Bedaquiline reprograms central metabolism to reveal glycolytic vulnerability in Mycobacterium tuberculosis.贝达喹啉重新编程中央代谢途径以揭示结核分枝杆菌的糖酵解脆弱性。
Nat Commun. 2020 Nov 30;11(1):6092. doi: 10.1038/s41467-020-19959-4.

引用本文的文献

1
Bidirectional two-sample Mendelian randomization reveals causal link between genetic blood metabolites and tuberculosis.双向双样本孟德尔随机化揭示了血液中遗传代谢物与结核病之间的因果关系。
AMB Express. 2025 Jun 14;15(1):92. doi: 10.1186/s13568-025-01901-w.
2
Reactive extraction of methanesulfonic acid from wastewater using trioctylamine.使用三辛胺从废水中反应萃取甲磺酸。
Sci Rep. 2024 Dec 3;14(1):30029. doi: 10.1038/s41598-024-81916-8.
3
Implementation of Modern Therapeutic Drug Monitoring and Lipidomics Approaches in Clinical Practice: A Case Study with Colistin Treatment.
现代治疗药物监测和脂质组学方法在临床实践中的应用:以黏菌素治疗为例的案例研究
Pharmaceuticals (Basel). 2024 Jun 7;17(6):753. doi: 10.3390/ph17060753.
4
A link between pH homeostasis and colistin resistance in bacteria.pH 值稳态与细菌中介导黏菌素耐药性的关联。
Sci Rep. 2021 Jun 24;11(1):13230. doi: 10.1038/s41598-021-92718-7.
5
Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus.具有抗结核作用的潜在研究化合物和具有重新定位潜力的抗结核治疗药物:概述。
Appl Microbiol Biotechnol. 2020 Jul;104(13):5633-5662. doi: 10.1007/s00253-020-10606-y. Epub 2020 May 5.